Authors:
MCDONALD R
BALMFORTH AJ
PALMER ACV
BALL SG
PEERS C
VAUGHAN PFT
Citation: R. Mcdonald et al., THE EFFECT OF THE ANGIOTENSIN-II (AT(1A)) RECEPTOR STABLY TRANSFECTEDINTO HUMAN NEUROBLASTOMA SH-SY5Y CELLS ON NORADRENALINE RELEASE AND CHANGES IN INTRACELLULAR CALCIUM, Neuroscience letters, 199(2), 1995, pp. 115-118
Citation: Sg. Ball et al., STRUCTURAL IMPLICATIONS OF ALTERNATIVE SPLICING IN TYPE-VI COLLAGEN, Biochemical Society transactions, 23(4), 1995, pp. 514-514
Citation: Bps. Bajaj et al., PHOTOLABELING IMPLICATES AN AMINO-ACID IN THE 2ND TRANSMEMBRANE DOMAIN OF THE RAT AT(1A)-RECEPTOR IN AGONIST BINDING, Biochemical Society transactions, 23(1), 1995, pp. 86-86
Authors:
BALL SG
OTTO MW
POLLACK MH
UCCELLO R
ROSENBAUM JF
Citation: Sg. Ball et al., DIFFERENTIATING SOCIAL PHOBIA AND PANIC DISORDER - A TEST OF CORE BELIEFS, Cognitive therapy and research, 19(4), 1995, pp. 473-482
Citation: Sg. Ball et al., DEPRESSION AND GENERALIZED ANXIETY SYMPTOMS IN PANIC DISORDER - IMPLICATIONS FOR COMORBIDITY, The Journal of nervous and mental disease, 183(5), 1995, pp. 304-308
Citation: C. Martinez et Sg. Ball, COST-EFFECTIVENESS OF RAMIPRIL THERAPY FOR PATIENTS WITH CLINICAL-EVIDENCE OF HEART-FAILURE AFTER ACUTE MYOCARDIAL-INFARCTION, British journal of clinical practice, 1995, pp. 26-32
Citation: As. Hall et Sg. Ball, ACE-INHIBITOR THERAPY AFTER MYOCARDIAL-INFARCTION - A NEW TREATMENT STRATEGY, Zeitschrift fur Kardiologie, 83, 1994, pp. 57-62
Authors:
TURNER NA
RUMSBY MG
WALKER JH
MCMORRIS FA
BALL SG
VAUGHAN PFT
Citation: Na. Turner et al., A ROLE FAR PROTEIN-KINASE-C SUBTYPE-ALPHA AND SUBTYPE-EPSILON IN PHORBOL-ESTER-ENHANCED K-EVOKED AND CARBACHOL-EVOKED NORADRENALINE RELEASEFROM THE HUMAN NEUROBLASTOMA SH-SY5Y(), Biochemical journal, 297, 1994, pp. 407-413
Citation: Sg. Ball et al., ACE-INHIBITION, ATHEROSCLEROSIS AND MYOCARDIAL-INFARCTION - THE AIRE STUDY IN PRACTICE, European heart journal, 15, 1994, pp. 20-25
Authors:
BUHLER FR
BALL SG
BAUMGARTNER HR
ERTEM G
FERRANNINI E
GOLDSTEIN S
KARPOV YA
KIOWSKI W
WIDMANN T
ZANCHETTI A
Citation: Fr. Buhler et al., A VASCULAR PROTECTIVE CONCEPT IN HYPERTENSION AND HEART-FAILURE, Journal of cardiovascular pharmacology, 24, 1994, pp. 190000001-190000004
Citation: Cm. Oneill et al., EFFECTS OF ISCHEMIC CONDITIONS ON UPTAKE OF GLUTAMATE, ASPARTATE, ANDNORADRENALINE BY CELL-LINES DERIVED FROM THE HUMAN NERVOUS-SYSTEM, Journal of neurochemistry, 63(2), 1994, pp. 603-611
Citation: Sg. Ball et al., PREDICTING PROSPECTIVE EPISODES OF DEPRESSION IN PATIENTS WITH PANIC DISORDER - A LONGITUDINAL-STUDY, Journal of consulting and clinical psychology, 62(2), 1994, pp. 359-365
Citation: As. Hall et al., INHIBITION OF ACE KININASE-II, ACUTE MYOCARDIAL-INFARCTION, AND SURVIVAL/, Cardiovascular Research, 28(2), 1994, pp. 190-198
Authors:
BALMFORTH AJ
BRYSON SE
AYLETT AJ
WARBURTON P
BALL SG
PUN KT
MIDDLEMISS D
DREW GM
Citation: Aj. Balmforth et al., COMPARATIVE PHARMACOLOGY OF RECOMBINANT RAT AT(1A), AT(1B) AND HUMAN AT(1) RECEPTORS EXPRESSED BY TRANSFECTED COS-M6 CELLS, British Journal of Pharmacology, 112(1), 1994, pp. 277-281
Citation: Sg. Ball et As. Hall, WHAT TO EXPECT FROM ACE-INHIBITORS AFTER MYOCARDIAL-INFARCTION, British Heart Journal, 72(3), 1994, pp. 190000070-190000074
Citation: Rl. Mcdonald et al., BRADYKININ-EVOKED RELEASE OF [H-3] NORADRENALINE FROM THE HUMAN NEUROBLASTOMA SH-SY5Y, Biochemical pharmacology, 48(1), 1994, pp. 23-30
Citation: As. Hall et al., PHENOXYBENZAMINE MEDIATED INHIBITION OF THE VASCULAR DOPAMINE D(1)-RECEPTOR, European journal of pharmacology. Molecular pharmacology section, 247(3), 1993, pp. 249-255
Authors:
OTTERSTAD JE
DAVIES M
BALL SG
ERIKSSEN J
BIRKIN E
VIRK S
RYNNING SE
RODEVAND O
HANSSON L
BERGBRANDT A
FINDLAY I
KHOKHAR AA
ARESKOG NH
NYLANDER E
SMITH S
MARLOW HF
Citation: Je. Otterstad et al., LEFT-VENTRICULAR HYPERTROPHY AND MYOCARDIAL-ISCHEMIA IN HYPERTENSION - THE THAMES STUDY, European heart journal, 14(12), 1993, pp. 1622-1628
Citation: Sg. Ball et F. Navarrolopez, THE ROLE OF ACE-INHIBITION IN HEART-FAILURE AND ATHEROSCLEROSIS, Journal of cardiovascular pharmacology, 22, 1993, pp. 180000005-180000005